Stoke Therapeutics (STOK.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec5

Stoke Therapeutics and Biogen Show Positive Data for Dravet Syndrome Drug

14:00

Dec1

Stoke Therapeutics and Biogen to Present New Clinical Data on Zorevunersen at AES Annual Meeting

12:30

Nov7

HC Wainwright Cuts Stoke Therapeutics 2029 EPS Forecast

14:26

Nov5

Stoke Therapeutics to Speak on Zorevunersen at Guggenheim Healthcare Innovation Conference

21:02

Stoke Therapeutics released FY2025 9 Months earnings on November 4 After-Market (EST), actual revenue USD 183.02 M, actual EPS USD 0.8433

00:00

Stoke Therapeutics released FY2025 Q3 earnings on November 4 After-Market EST, actual revenue USD 10.63 M (forecast USD 6.16 M), actual EPS USD -0.6542 (forecast USD -0.577)

00:00

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 10.63 M, Net Income -38.35 M, EPS -0.6542

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 13.82 M, Net Income -23.48 M, EPS -0.4024

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 158.57 M, Net Income 112.88 M, EPS 1.9

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change